Long-Term Results of Combined Modularized, Immune-Modulatory, Angiostatic, and Antiinflammatory Therapy in Systemically Pre-Treated Multi-Systems Langerhans Cell Histiocytosis
作者： A. Reichle , M. Vogelhuber , T. Vogt , L. Kunz-Schughart , T. Bretschneider
DOI: 10.1007/978-94-007-6866-6_4
关键词:
摘要: Up to now, systemically pretreated multi-systems Langerhans cell histiocytosis has been an incurable disease, and therapeutic options for patients have been limited. Acknowledging …
springer.com
sci-hub.st 参考文章(19)
Urban Emmenegger, Annabelle Chow, Guido Bocci, The Biomodulatory Capacities of Low-Dose Metronomic Chemotherapy: Complex Modulation of the Tumor Microenvironment Springer, Dordrecht. pp. 243- 262 ,(2010) , 10.1007/978-90-481-9531-2_11
Helena Pavlakovic, Volker Von Sch�tz, Jochen R�ssler, Ewa Koscielniak, Werner Havers, Lothar Schweigerer, Quantification of angiogenesis stimulators in children with solid malignancies. International Journal of Cancer. ,vol. 92, pp. 756- 760 ,(2001) , 10.1002/1097-0215(20010601)92:5<756::AID-IJC1253>3.0.CO;2-F
A. Reichle, Th. Vogt, L. Kunz-Schughart, Th. Bretschneider, M. Bachthaler, K. Bross, S. Freund, R. Andreesen, Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans' cell histiocytosis of adults. British Journal of Haematology. ,vol. 128, pp. 730- 732 ,(2005) , 10.1111/J.1365-2141.2004.05359.X
M. Minkov, N. Grois, A. Heitger, U. Pötschger, T. Westermeier, H. Gadner, Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Klinische Padiatrie. ,vol. 212, pp. 139- 144 ,(2000) , 10.1055/S-2000-9667
Julien Haroche, Fleur Cohen-Aubart, Jean-François Emile, Laurent Arnaud, Philippe Maksud, Frédéric Charlotte, Philippe Cluzel, Aurélie Drier, Baptiste Hervier, Neïla Benameur, Sophie Besnard, Jean Donadieu, Zahir Amoura, Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation Blood. ,vol. 121, pp. 1495- 1500 ,(2013) , 10.1182/BLOOD-2012-07-446286
Felix Sahm, David Capper, Matthias Preusser, Jochen Meyer, Albrecht Stenzinger, Felix Lasitschka, Anna-Sophie Berghoff, Antje Habel, Marion Schneider, Andreas Kulozik, Ioannis Anagnostopoulos, Leonhard Müllauer, Gunhild Mechtersheimer, Andreas von Deimling, BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood. ,vol. 120, ,(2012) , 10.1182/BLOOD-2012-06-429597
R.E. Brown, The NF-kappaB pathway and the successful application of anti-inflammatory and angiostatic therapy in Langerhans' cell histiocytosis. British Journal of Haematology. ,vol. 130, pp. 147- 148 ,(2005) , 10.1111/J.1365-2141.2005.05575.X
Frederic Geissmann, Yves Lepelletier, Sylvie Fraitag, Jenny Valladeau, Christine Bodemer, Marianne Debré, Michelle Leborgne, Sem Saeland, Nicole Brousse, Differentiation of Langerhans cells in Langerhans cell histiocytosis Blood. ,vol. 97, pp. 1241- 1248 ,(2001) , 10.1182/BLOOD.V97.5.1241
Helmut Gadner, Nicole Grois, Maurizio Arico, Valerie Broadbent, Adriana Ceci, Ake Jakobson, Diane Komp, Jörg Michaelis, Stacy Nicholson, Ulrike Pötschger, Jon Pritchard, Stephan Ladisch, Histiocyte Society, A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. The Journal of Pediatrics. ,vol. 138, pp. 728- 734 ,(2001) , 10.1067/MPD.2001.111331
Albrecht Reichle, Klaus Bross, Thomas Vogt, Frauke Bataille, Peter Wild, Anna Berand, Stefan W. Krause, Reinhard Andreesen, Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma. Cancer. ,vol. 101, pp. 2247- 2256 ,(2004) , 10.1002/CNCR.20574